Underestimation of impaired glucose tolerance and usefulness of a continuous glucose monitoring system in chronic liver disease

The prevalence of glucose intolerance in chronic liver disease patients is high, but glucose intolerance may be overlooked in a single blood test. The purpose of this study is to evaluate blood glucose variability in patients with chronic liver disease by a continuous glucose monitoring system (CGMS) and to examine the discrepancy between hemoglobin A1c (HbA1c) levels estimated from average blood glucose levels and HbA1c.

[1]  K. Chayama,et al.  Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 , 2021, Journal of Gastroenterology.

[2]  H. Yoshiji,et al.  Evidence-based clinical practice guidelines for Liver Cirrhosis 2020 , 2021, Journal of Gastroenterology.

[3]  A. Goto,et al.  Japanese Clinical Practice Guideline for Diabetes 2019 , 2020, Journal of diabetes investigation.

[4]  A. Goto,et al.  Japanese Clinical Practice Guideline for Diabetes 2019 , 2020, Diabetology International.

[5]  M. Imamura,et al.  Risk factors for histological progression of nonalcoholic steatohepatitis analyzed from repeated biopsy cases. , 2020, Journal of gastroenterology and hepatology.

[6]  M. Imamura,et al.  Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring , 2018, PloS one.

[7]  C. Datz,et al.  Obesity as an Emerging Risk Factor for Iron Deficiency , 2014, Nutrients.

[8]  T. Saibara,et al.  Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients , 2014, Journal of Gastroenterology.

[9]  FACE Michael S. Radin MD,et al.  Pitfalls in Hemoglobin A1c Measurement: When Results may be Misleading , 2013, Journal of General Internal Medicine.

[10]  S. Rodriguez-Segade,et al.  Translating the A1C Assay Into Estimated Average Glucose Values , 2009, Diabetes Care.

[11]  D. Schoenfeld,et al.  Translating the A1C Assay Into Estimated Average Glucose Values , 2008, Diabetes Care.

[12]  G. D’Amico,et al.  Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. , 2006, Journal of hepatology.

[13]  H. El‐Serag,et al.  Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. , 2004, Gastroenterology.

[14]  T. Md.  Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin , 2004, Diabetologia.

[15]  Michael Roden,et al.  Hepatic glucose metabolism in humans--its role in health and disease. , 2003, Best practice & research. Clinical endocrinology & metabolism.

[16]  G M Steil,et al.  Can interstitial glucose assessment replace blood glucose measurements? , 2000, Diabetes technology & therapeutics.

[17]  Y. Nakatani,et al.  Impaired splanchnic and peripheral glucose uptake in liver cirrhosis. , 1999, Journal of hepatology.

[18]  A. Petrides.  [Hepatogenic diabetes: pathophysiology, therapeutic options and prognosis]. , 1999, Zeitschrift fur Gastroenterologie.

[19]  M. Serra,et al.  Liver cirrhosis and diabetes mellitus. , 1996, Journal of hepatology.

[20]  G. Marchesini,et al.  Prognostic significance of diabetes in patients with cirrhosis , 1994, Hepatology.

[21]  C. Mussini,et al.  Fructosamine and glycated hemoglobin as indices of glycemic control in patients with liver cirrhosis , 1990, La Ricerca in clinica e in laboratorio.

[22]  K. Nanjo,et al.  Hemoglobin A1 in cirrhosis of the liver. , 1989, Diabetes research.

[23]  A. Varriale,et al.  Abnormalities of glucose metabolism induced by liver cirrhosis and glycosylated hemoglobin levels in chronic liver disease. , 1988, Diabetes research.

[24]  R. Casamitjana,et al.  Role of spontaneous portal-systemic shunting in hyperinsulinism of cirrhosis. , 1984, The American journal of physiology.

[25]  Y. Akanuma,et al.  Degradation and secretion of insulin in hepatic cirrhosis. , 1978, The Journal of clinical endocrinology and metabolism.

[26]  D. Johnston,et al.  HYPERINSULINISM OF HEPATIC CIRRHOSIS: DIMINISHED DEGRADATION OR HYPERSECRETION? , 1977, The Lancet.

[27]  G. Mariani,et al.  Serum albumin turnover in liver cirrhosis. , 1974, The Journal of nuclear biology and medicine.

[28]  V. Bosnjaković,et al.  Characteristics of albumin turnover in different stages of cirrhosis of liver evaluated by means of radioisotope technique and analog computer analysis. , 1972, Radiobiologia, radiotherapia.

[29]  A. Al-Hindawi,et al.  Red Cell Survival and Splenic Accumulation of Radiochromium in Liver Cirrhosis with Splenomegaly , 1967, British journal of haematology.

[30]  C. G. Child,et al.  Surgery and portal hypertension. , 1964, Major problems in clinical surgery.